Differentially Expressed Genes Associated with the Development of Cervical Cancer

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Cervical cancer is a major cause of cancer mortality, especially in low- and middle-income countries.
• High-throughput technologies like microarrays enable comprehensive gene expression analysis in cervical cancer.
• Identifying differentially expressed genes (DEGs) is crucial for understanding pathogenesis and finding therapeutic targets.

Purpose of the Study:

• To identify DEGs, potential biomarkers, and therapeutic targets for cervical cancer.
• To perform bioinformatic analysis for gene ontology and miRNA targets related to DEGs.
• To associate identified genes with cervical cancer progression and clinical outcomes.

Main Methods:

• Utilized publicly available microarray datasets (GSE39001, GSE9750, GSE7803, GSE6791, GSE63514, GSE52903).
• Combined microarray data with bioinformatics database predictions to identify DEGs.
• Conducted bioinformatic analysis for gene ontology and miRNA target prediction.

Main Results:

• Identified several DEGs associated with cervical cancer progression, including those involved in cell death and DNA replication.
• Key transcription factors (TFs) identified include SP1, ELF3, E2F1, TP53, RELA, HDAC, and FOXM1.
• Found 11 upregulated and 14 downregulated coding genes significantly associated with cervical cancer; identified hub proteins potentially regulated by specific miRNAs.

Conclusions:

• The identified DEGs and TFs show significant association with cervical cancer progression.
• These genes hold potential as candidate biomarkers for cervical cancer diagnosis, treatment, and prognosis.
• Further research into these identified genes and their miRNA regulation is warranted.